Quantum-Si incorporated (NASDAQ:QSI – Get Free Report) CFO Jeffry R. Keyes sold 8,626 shares of the firm’s stock in a transaction on Friday, March 21st. The shares were sold at an average price of $1.39, for a total value of $11,990.14. Following the transaction, the chief financial officer now directly owns 1,188,194 shares in the company, valued at $1,651,589.66. This trade represents a 0.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.
Quantum-Si Price Performance
Quantum-Si stock traded up $0.03 during midday trading on Monday, reaching $1.48. The stock had a trading volume of 7,168,237 shares, compared to its average volume of 9,480,965. The firm’s fifty day simple moving average is $1.79 and its two-hundred day simple moving average is $1.48. The firm has a market cap of $271.05 million, a price-to-earnings ratio of -2.31 and a beta of 2.75. Quantum-Si incorporated has a twelve month low of $0.61 and a twelve month high of $5.77.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the business. Wolverine Asset Management LLC purchased a new position in Quantum-Si during the 4th quarter valued at about $26,000. Abel Hall LLC acquired a new position in Quantum-Si in the 4th quarter valued at approximately $28,000. Dudley Capital Management LLC purchased a new stake in shares of Quantum-Si during the fourth quarter worth $30,000. Jump Financial LLC acquired a new stake in Quantum-Si during the fourth quarter valued at $33,000. Finally, Cetera Investment Advisers purchased a new stake in shares of Quantum-Si during the 4th quarter worth about $36,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Quantum-Si
About Quantum-Si
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Further Reading
- Five stocks we like better than Quantum-Si
- Best Stocks Under $5.00
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Stock Market Sectors: What Are They and How Many Are There?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Plot Fibonacci Price Inflection Levels
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.